Navigation Links
Young scientists turn to gel to ease side-effects of cancer treatment

Three young scientists in the University of York's Department of Chemistry have developed a gel that could spare cancer patients some of the unpleasant and dangerous side-effects of radiotherapy.

PhD students Andrew Wilson and Paul Watson, together with post-doctoral research fellow Mark Godber, have developed the gel which will help doctors to target cancer tumours more efficiently.

Now, the group has secured £30,000 under the Bioscience Yorkshire Enterprise Fellowship scheme to commercialise their idea.

Their product, a formulation of various chemicals, is a gelatine whose density is comparable with human tissue and can be tailored for different applications.

"This technique should allow more rapid, accurate, and therefore safer treatment of malignant tumours" Andrew Wilson. The density of the gel alters when subjected to radiation beams, so radiologists can use it to take the guesswork out of the intensity-modulated radiation therapy treatment of malignant cancers.

By testing the radiation beam on the gel first, radiologists can judge more accurately the precise dose needed to treat the tumour, enabling them to calibrate their machines accordingly.

Andrew Wilson said: "This technique should allow more rapid, accurate, and therefore safer treatment of malignant tumours."

A different formula of the gel can be used as a phantom in the detection of brain tumours. Working with researchers at the Centre for Magnetic Resonance Investigations, at Hull Royal Infirmary, the team has developed a technique which uses the gel to improve the accuracy of targeting tumour cells.

Magnetic Resonance Spectroscopy can be used as an imaging technique allowing the tumour to be identified accurately, because of the differing biological activity in tumour cells compared with healthy cells. A phantom is required to prove the accuracy of these measurements.

The team has already supplied samples of the gels to the Princess Royal Hospital in Hull and hope to go into commercial production soon.


'"/>

Source:University of York


Related biology news :

1. Young Blood Revives Aging Muscles, Stanford Researchers Find
2. Wisconsin scientists grow critical nerve cells
3. UCSB scientists probe sea floor venting to gain understanding of early life on Earth
4. UAB scientists discover the origin of a mysterious physical force
5. Fox Chase Cancer Center scientists identify immune-system mutation
6. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
7. U-M scientists find genes that control growth of common skin cancer
8. UCLA scientists transform HIV into cancer-seeking missile
9. RNA project to create language for scientists worldwide
10. Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals
11. To control germs, scientists deploy tiny agents provocateurs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... their customers enhanced security to access and transact ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
Breaking Biology News(10 mins):
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... Lawrence, MA (PRWEB) , ... June 23, 2016 ... ... the Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research ... test platform of microbial tests introduced last year,” stated Bob Salter, Vice President ...
Breaking Biology Technology: